BioCentury
ARTICLE | Financial News

GNSL lowers revenue guidance

September 28, 2001 7:00 AM UTC

Research tool developer Genomic Solutions (GNSL) lowered projected revenues for the third quarter to $3.5-$3.7 million following the impact on sales of the Sept. 11 attacks. The company said still exp...